Plain-English translation of NCT05776927 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study compares a new asthma inhaler called to a standard asthma treatment that many teenagers already use. The trial will test whether controls asthma symptoms better and is safe for teenagers aged 12 to 17. You would try each treatment for 12 weeks to help researchers understand which one works best.
Many teenagers with asthma still have symptoms even while taking the current standard medications. Researchers want to know if this new treatment can help more teenagers breathe easier and have better control of their asthma.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic multiple times over nine months. First, there is a short screening and two-week run-in period where you take a standard asthma medication. Then you randomly receive either the new inhaler or your current treatment for 12 weeks, followed by a three-week break where you return to a standard medication, then switch to whichever treatment you didn't try first for another 12 weeks. Throughout, you complete breathing tests, keep track of your symptoms, and have follow-up visits to check that the treatment is working and is safe.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
Argentina
France
Germany
Hungary